Sectors

SUPN
Supernus Pharmaceuticals, Inc.
47.30
1 x 46.13
1 x 47.07
bid
ask
+
0.23
0.50%
09:38 AM
timesize
Ytd-4.82%
1y16.60%
47.01
day range
47.59
40.50
52 week range
59.68
Open47.59Prev Close47.07Low47.01High47.59Mkt Cap2.75B
Vol5.36KAvg Vol853.85KEPS3.06P/E15.46Forward P/E10.68
Beta0.56Short Ratio4.88Inst. Own104.10%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0450-d Avg46.18200-d Avg48.901yr Est61.75

SUPN News

California State Teachers Retirement System Grows Stock Holdings in Supernus Pharmaceuticals, Inc. $SUPN
defenseworld.net
California State Teachers Retirement System Grows Stock Holdings in Supernus Pharmaceuticals, Inc. $

California State Teachers Retirement System lifted its stake in Supernus Pharmaceuticals, Inc. (NASD

Are BOW, ATKR, SUPN Obtaining Fair Deals for their Shareholders?
prnewswire.com
Are BOW, ATKR, SUPN Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?
zacks.com
SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?

Investors with an interest in Medical - Generic Drugs stocks have likely encountered both Supernus P

Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN
gurufocus.com
Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and P

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swic

Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN
businesswire.com
Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and P

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

New Strong Buy Stocks for August 7th
zacks.com
New Strong Buy Stocks for August 7th

EDRY, OPBK, SUPN, MSBI and NXRT have been added to the Zacks Rank #1 (Strong Buy) List on August 7th

Best Value Stocks to Buy for August 7th
zacks.com
Best Value Stocks to Buy for August 7th

BCAL, SUPN and NXRT made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 7th, 2026.

INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook
zacks.com
INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook

Indivior announces a merger with Supernus to form a CNS-focused biopharma company, tops Q2 earnings

Top 3 Health Care Stocks You'll Regret Missing This Quarter
benzinga.com
Top 3 Health Care Stocks You'll Regret Missing This Quarter

The most oversold health care stocks present a buying opportunity. RSI indicator compares stock stre

Supernus to Combine with Indivior To Form CNS Biopharmaceutical Leader with Potential $2 Billion in Revenue
benzinga.com
Supernus to Combine with Indivior To Form CNS Biopharmaceutical Leader with Potential $2 Billion in

Supernus and Indivior agree to merge in an all-stock deal, targeting $2.2 billion in revenue and $12

benzinga.com
UPDATE: Supernus Pharmaceuticals Q2 Adj. EPS $0.53 Beats $0.42 Estimate

Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly earnings of $0.53 per share which beat the

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 121.2% to $6.99 during Monday'

benzinga.com
Supernus Pharmaceuticals To Merge With Indivior Pharmaceuticals; SUPN Stockholders Will Receive 1.54

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) and Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) today

benzinga.com
Cantor Fitzgerald Maintains Overweight on Supernus Pharmaceuticals, Raises Price Target to $67

Cantor Fitzgerald analyst Kristen Kluska maintains Supernus Pharmaceuticals (NASDAQ:SUPN) with a

Supernus Pharmaceuticals Q1 2026 Earnings Call Transcript
benzinga.com
Supernus Pharmaceuticals Q1 2026 Earnings Call Transcript

benzinga.com
Supernus Pharmaceuticals Affirms FY2026 Sales Guidance of $840.000M-$870.000M vs $862.242M Est

Supernus Pharmaceuticals (NASDAQ:SUPN) affirms FY2026 sales outlook from $840.000 million-$870.000 m

benzinga.com
Supernus Pharmaceuticals Q1 EPS $(0.04) Misses $(0.01) Estimate, Sales $207.705M Beat $192.918M Esti

Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly losses of $(0.04) per share which missed t

Earnings Scheduled For May 5, 2026
benzinga.com
Earnings Scheduled For May 5, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

benzinga.com
Supernus Pharmaceuticals Sees FY2026 Sales $840.000M-$870.000M vs $860.987M Est

Supernus Pharmaceuticals (NASDAQ:SUPN) sees FY2026 sales of $840.000 million-$870.000 million vs $86

Supernus Pharmaceuticals: Q4 Earnings Insights
benzinga.com
Supernus Pharmaceuticals: Q4 Earnings Insights

benzinga.com
Supernus Pharmaceuticals Q4 EPS $(0.07) Beats $(0.16) Estimate, Sales $211.572M Beat $195.004M Estim

Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly losses of $(0.07) per share which beat the

Earnings Scheduled For February 24, 2026
benzinga.com
Earnings Scheduled For February 24, 2026

Insights into Supernus Pharmaceuticals's Upcoming Earnings
benzinga.com
Insights into Supernus Pharmaceuticals's Upcoming Earnings

Earnings Scheduled For November 4, 2025
benzinga.com
Earnings Scheduled For November 4, 2025

benzinga.com
Earnings Scheduled For August 5, 2025

benzinga.com
Earnings Scheduled For May 6, 2025

benzinga.com
Earnings Scheduled For February 25, 2025

This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
benzinga.com
This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

benzinga.com
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday

benzinga.com
Earnings Scheduled For February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los

benzinga.com
Earnings Scheduled For November 8, 2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 647 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 369 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  During Tuesday's session, 275 companies made new 52-week lows.

benzinga.com
Earnings Scheduled For August 8, 2023

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

benzinga.com
Earnings Scheduled For May 9, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

benzinga.com
Earnings Scheduled For February 28, 2023

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for

benzinga.com
Earnings Scheduled For August 4, 2022

  Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for

benzinga.com
Earnings Scheduled For February 28, 2022

  Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to repo

benzinga.com
Earnings Scheduled For November 3, 2021

  Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report qu

benzinga.com
Earnings Scheduled For May 5, 2021

  Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnin

benzinga.com
Stocks That Hit 52-Week Highs On Wednesday

    During Wednesday's morning session, 226 stocks hit new 52-week highs.

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2021

 

benzinga.com
Earnings Scheduled For February 25, 2021

  Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings

benzinga.com
Stocks That Hit 52-Week Highs On Wednesday

    This morning 533 companies reached new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Highs On Wednesday

    Before 10 a.m. ET on Wednesday, 375 companies hit new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Highs On Friday

  This morning 150 companies reached new 52-week highs.

benzinga.com
80 Biggest Movers From Yesterday

Gainers